Acute bronchiolitis is a viral disease usually common in infants and occurs mainly in winter. Treatment of the disease is primarily supportive and based on maintaining hydration and oxygen supplementation when needed.
In recent years, quite a number of studies around the world have proven the effectiveness of treatment with hypertonic saline inhalation in infants, hospitalized due to acute bronchiolitis.
Hypertonic saline inhalation therapy resulted in clinical improvement and shortening of the duration of hospitalization.
Hypertonic saline works by raising fluid lining in the airway walls and reducing the edema layer of the sub-mucosa. It improves rheological properties of sputum and accelerates the mucus clearance (MC).
- For respiratory use with inhalators in cases of bronchiolitis – RSV infections:
The inhalation of RSV hypertonic saline 3% should be administered in a volume of 4 ml, 3-6 times a day. In light cases, dosage can be reduced to 0-3 ml volume of liquid inhaled. Bronchodilators can be added. Such treatment can be administered at home, in clinics or emergency rooms.
- As nasal hygiene: Apply as needed.